Best TWAS P=8.25e-116 · Best GWAS P=9.11e-97 conditioned to 1
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GTEx | Adipose Subcutaneous | ADAM19 | 0.09 | 0.08 | lasso | 6 | 0.05 | 5.6e-05 | -20.71 | -20.6 | 2.8e-94 | 0.99 | 0.00 | 0.99 | FALSE |
2 | GTEx | Adrenal Gland | ADAM19 | 0.17 | 0.08 | enet | 1 | 0.06 | 3.6e-03 | -5.20 | -5.2 | 2.0e-07 | 0.31 | 0.20 | 0.72 | TRUE |
3 | GTEx | Artery Tibial | ADAM19 | 0.09 | 0.00 | enet | 21 | 0.01 | 3.0e-02 | -16.67 | -14.6 | 3.6e-48 | 0.59 | 0.12 | 0.58 | TRUE |
4 | GTEx | Brain Hypothalamus | MED7 | 0.30 | 0.02 | enet | 30 | 0.02 | 1.0e-01 | -0.76 | -6.1 | 1.2e-09 | 0.02 | 0.07 | 0.06 | FALSE |
5 | GTEx | Breast Mammary Tissue | ADAM19 | 0.11 | 0.10 | lasso | 1 | 0.06 | 3.6e-04 | -20.70 | -20.7 | 3.3e-95 | 1.00 | 0.01 | 0.99 | FALSE |
6 | GTEx | Breast Mammary Tissue (Male) | ADAM19 | 0.08 | 0.03 | lasso | 1 | -0.01 | 7.7e-01 | 14.16 | -14.2 | 1.7e-45 | 0.21 | 0.05 | 0.21 | FALSE |
7 | GTEx | Breast Mammary Tissue (Female) | ADAM19 | 0.11 | 0.14 | lasso | 6 | 0.10 | 5.1e-04 | -20.87 | -20.5 | 6.0e-93 | 0.98 | 0.01 | 0.92 | TRUE |
8 | GTEx | Cells Transformed fibroblasts | THG1L | 0.21 | 0.08 | enet | 34 | 0.12 | 2.1e-09 | 2.36 | -5.7 | 1.3e-08 | 0.30 | 0.94 | 0.01 | FALSE |
9 | GTEx | Cells Transformed fibroblasts | ADAM19 | 0.16 | 0.02 | enet | 17 | 0.06 | 3.0e-05 | 12.33 | -21.8 | 3.7e-105 | 0.63 | 0.05 | 0.94 | FALSE |
10 | GTEx | Colon Sigmoid | CYFIP2 | 0.24 | 0.26 | lasso | 5 | 0.24 | 6.2e-09 | -13.36 | -13.5 | 1.0e-41 | 0.28 | 0.98 | 0.00 | FALSE |
11 | GTEx | Esophagus Mucosa | ADAM19 | 0.14 | 0.03 | enet | 19 | 0.09 | 2.4e-06 | 8.22 | -18.6 | 1.7e-77 | 0.57 | 0.06 | 0.90 | FALSE |
12 | GTEx | Muscle Skeletal | ADAM19 | 0.06 | 0.02 | lasso | 4 | 0.01 | 1.5e-02 | -20.87 | -21.9 | 4.4e-106 | 0.88 | 0.01 | 0.99 | FALSE |
13 | GTEx | Nerve Tibial | ADAM19 | 0.34 | 0.16 | enet | 45 | 0.30 | 1.2e-21 | -15.24 | -19.3 | 9.6e-83 | 0.78 | 0.01 | 0.99 | FALSE |
14 | GTEx | Ovary | ADAM19 | 0.32 | 0.11 | lasso | 9 | 0.08 | 6.5e-03 | -11.79 | -18.3 | 5.4e-75 | 0.65 | 0.05 | 0.73 | TRUE |
15 | GTEx | Skin Not Sun Exposed Suprapubic | ADAM19 | 0.10 | 0.01 | lasso | 4 | 0.08 | 5.2e-05 | -15.72 | -20.8 | 1.9e-96 | 0.75 | 0.02 | 0.98 | FALSE |
16 | GTEx | Skin Sun Exposed Lower leg | ADAM19 | 0.07 | 0.04 | lasso | 6 | 0.06 | 1.2e-05 | -14.86 | -21.5 | 1.3e-102 | 0.80 | 0.02 | 0.98 | TRUE |
17 | GTEx | Skin Sun Exposed Lower leg | MED7 | 0.07 | 0.01 | enet | 7 | 0.01 | 4.6e-02 | 14.33 | 10.8 | 2.3e-27 | -0.12 | 0.23 | 0.08 | FALSE |
18 | GTEx | Stomach | ADAM19 | 0.15 | 0.00 | enet | 5 | 0.03 | 1.1e-02 | -8.71 | -11.1 | 1.9e-28 | 0.42 | 0.18 | 0.53 | FALSE |
19 | GTEx | Testis | ADAM19 | 0.16 | 0.00 | enet | 17 | -0.01 | 6.7e-01 | -15.16 | -21.7 | 1.5e-104 | 0.82 | 0.02 | 0.90 | FALSE |
20 | GTEx | Whole Blood | ADAM19 | 0.12 | 0.07 | enet | 20 | 0.07 | 9.8e-07 | -15.52 | -19.4 | 6.3e-84 | 0.57 | 0.89 | 0.11 | FALSE |
21 | METSIM | Adipose | ADAM19 | 0.08 | 0.07 | lasso | 9 | 0.07 | 2.5e-10 | -20.70 | -20.7 | 3.1e-95 | 1.00 | 0.00 | 1.00 | FALSE |
22 | NTR | Blood | HAVCR1 | 0.02 | 0.00 | bslmm | 479 | 0.01 | 3.9e-03 | -0.63 | 10.4 | 1.9e-25 | -0.14 | 0.06 | 0.03 | TRUE |
23 | ROSMAP | Brain Pre-frontal Cortex | ADAM19 | 0.14 | 0.04 | lasso | 5 | 0.05 | 5.8e-07 | -14.65 | 8.8 | 8.5e-19 | -0.34 | 0.77 | 0.01 | TRUE |
24 | ROSMAP | Brain Pre-frontal Cortex | FNDC9 | 0.09 | 0.02 | bslmm | 491 | 0.04 | 6.5e-06 | -15.19 | -14.1 | 5.0e-45 | 0.32 | 0.79 | 0.01 | FALSE |
25 | The Cancer Genome Atlas | Breast Invasive Carcinoma | CYFIP2 | 0.03 | 0.02 | blup | 136 | 0.02 | 8.3e-06 | -8.89 | -14.4 | 4.7e-47 | 0.53 | 0.22 | 0.62 | FALSE |
26 | The Cancer Genome Atlas | Colon Adenocarcinoma | NIPAL4 | 0.12 | 0.10 | blup | 71 | 0.11 | 1.1e-06 | 0.43 | -8.4 | 3.2e-17 | 0.45 | 0.77 | 0.18 | FALSE |
27 | The Cancer Genome Atlas | Glioblastoma Multiforme | NIPAL4 | 0.30 | 0.21 | blup | 69 | 0.23 | 1.7e-07 | 4.04 | 6.7 | 2.7e-11 | 0.09 | 0.53 | 0.04 | FALSE |
28 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | ADAM19 | 0.08 | 0.02 | blup | 159 | 0.03 | 5.3e-04 | -14.87 | -22.9 | 8.2e-116 | 0.70 | 0.04 | 0.76 | TRUE |
29 | The Cancer Genome Atlas | Lung Adenocarcinoma | ADAM19 | 0.09 | 0.03 | lasso | 4 | 0.05 | 2.4e-06 | -20.70 | -22.8 | 1.2e-114 | 0.83 | 0.01 | 0.98 | FALSE |
30 | The Cancer Genome Atlas | Prostate Adenocarcinoma | ADAM19 | 0.05 | 0.01 | blup | 159 | 0.03 | 9.5e-04 | 12.22 | -22.5 | 4.9e-112 | 0.57 | 0.06 | 0.25 | TRUE |
31 | The Cancer Genome Atlas | Soft Tissue Sarcoma | C5orf40 | 0.08 | 0.03 | blup | 79 | 0.05 | 6.7e-04 | -15.20 | -12.6 | 2.8e-36 | 0.56 | 0.01 | 0.97 | FALSE |
32 | The Cancer Genome Atlas | Thyroid Carcinoma | ADAM19 | 0.07 | 0.00 | blup | 159 | 0.02 | 2.0e-03 | 8.21 | -21.4 | 1.8e-101 | 0.49 | 0.15 | 0.18 | FALSE |
33 | The Cancer Genome Atlas | Uterine Corpus Endometrial Carcinoma | NIPAL4 | 0.20 | 0.08 | lasso | 2 | 0.14 | 1.3e-04 | 10.70 | -11.5 | 9.4e-31 | 0.34 | 0.12 | 0.24 | TRUE |